These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16476075)

  • 1. Human U937 monocyte behavior and protein expression on various formulations of three-dimensional fibrin clots.
    Mana M; Cole M; Cox S; Tawil B
    Wound Repair Regen; 2006; 14(1):72-80. PubMed ID: 16476075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical characterization of autologous fibrin sealants produced by CryoSeal and Vivostat in comparison to the homologous fibrin sealant product Tissucol/Tisseel.
    Buchta C; Hedrich HC; Macher M; Höcker P; Redl H
    Biomaterials; 2005 Nov; 26(31):6233-41. PubMed ID: 15921738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavior of human dermal fibroblasts in three-dimensional fibrin clots: dependence on fibrinogen and thrombin concentration.
    Cox S; Cole M; Tawil B
    Tissue Eng; 2004; 10(5-6):942-54. PubMed ID: 15265312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the mechanical, kinetic, and biochemical properties of fibrin clots formed with two different fibrin sealants.
    Hickerson WL; Nur I; Meidler R
    Blood Coagul Fibrinolysis; 2011 Jan; 22(1):19-23. PubMed ID: 21150581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of tranexamic acid incorporated in fibrin sealant clots on the cell behavior of neuronal and nonneuronal cells.
    Cox S; Cole M; Mankarious S; Tawil N
    J Neurosci Res; 2003 Jun; 72(6):734-46. PubMed ID: 12774314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The behavior of human mesenchymal stem cells in 3D fibrin clots: dependence on fibrinogen concentration and clot structure.
    Ho W; Tawil B; Dunn JC; Wu BM
    Tissue Eng; 2006 Jun; 12(6):1587-95. PubMed ID: 16846354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High thrombin concentrations in fibrin sealants induce apoptosis in human keratinocytes.
    Gugerell A; Schossleitner K; Wolbank S; Nürnberger S; Redl H; Gulle H; Goppelt A; Bittner M; Pasteiner W
    J Biomed Mater Res A; 2012 May; 100(5):1239-47. PubMed ID: 22359340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New method to prepare autologous fibrin glue on demand.
    Alston SM; Solen KA; Broderick AH; Sukavaneshvar S; Mohammad SF
    Transl Res; 2007 Apr; 149(4):187-95. PubMed ID: 17383592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of fibrin sealant composition on human neutrophil chemotaxis.
    Hanson AJ; Quinn MT
    J Biomed Mater Res; 2002 Sep; 61(3):474-81. PubMed ID: 12115473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell compatibility of fibrin sealants: in vitro study with cells involved in soft tissue repair.
    Macasev D; Diorio JP; Gugerell A; Goppelt A; Gulle H; Bittner M
    J Biomater Appl; 2011 Aug; 26(2):129-49. PubMed ID: 20624847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactivity of the vascular endothelial growth factor trapped in fibrin clots: production of IL-6 and IL-8 in monocytes by fibrin clots.
    Tezono K; Sarker KP; Kikuchi H; Nasu M; Kitajima I; Maruyama I
    Haemostasis; 2001; 31(2):71-9. PubMed ID: 11684862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrin sealant promotes migration and proliferation of human articular chondrocytes: possible involvement of thrombin and protease-activated receptors.
    Kirilak Y; Pavlos NJ; Willers CR; Han R; Feng H; Xu J; Asokananthan N; Stewart GA; Henry P; Wood D; Zheng MH
    Int J Mol Med; 2006 Apr; 17(4):551-8. PubMed ID: 16525709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin generation and fibrin clot structure.
    Wolberg AS
    Blood Rev; 2007 May; 21(3):131-42. PubMed ID: 17208341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrin sealant combined with fibroblasts and platelet-derived growth factor enhance wound healing in excisional wounds.
    Mogford JE; Tawil B; Jia S; Mustoe TA
    Wound Repair Regen; 2009; 17(3):405-10. PubMed ID: 19660049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrin sealants in clinical practice.
    Albala DM
    Cardiovasc Surg; 2003 Aug; 11 Suppl 1():5-11. PubMed ID: 12869982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferation of human keratinocytes and cocultured human keratinocytes and fibroblasts in three-dimensional fibrin constructs.
    Sese N; Cole M; Tawil B
    Tissue Eng Part A; 2011 Feb; 17(3-4):429-37. PubMed ID: 20807013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboelastograph assay for measuring the mechanical strength of fibrin sealant clots.
    Glidden PF; Malaska C; Herring SW
    Clin Appl Thromb Hemost; 2000 Oct; 6(4):226-33. PubMed ID: 11030529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor.
    von dem Borne PA; Cox LM; Bouma BN
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):251-7. PubMed ID: 16651866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability, sterility, coagulation, and immunologic studies of salmon coagulation proteins with potential use for mammalian wound healing and cell engineering.
    Laidmäe I; McCormick ME; Herod JL; Pastore JJ; Salum T; Sawyer ES; Janmey PA; Uibo R
    Biomaterials; 2006 Dec; 27(34):5771-9. PubMed ID: 16919721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of pooled fibrin sealant for ear surgery.
    Siedentop KH; Chung SE; Park JJ; Sanchez B; Bhattacharya T; Marx G
    Am J Otol; 1997 Sep; 18(5):660-4. PubMed ID: 9303166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.